Artiva upsizes IPO to $167 million as NK cell therapy biotech heads to Nasdaq 19.07.2024 11:58 Fiercebiotech.com Artiva upsizes IPO to $167 million as NK cell therapy biotech heads to Nasdaq jwaldron Fri, 07/19/2024 - 04:58
